Metabolic disorders associated with uncontrolled hypertension. Skaraborg hypertension and diabetes project

Diabetes, Obesity and Metabolism

Volumn 5, Issue 6, 2003, Pages 379-387

  Bøg Hansen, Erik ^a,b   Lindblad, U ^a,c   Gullberg, B ^a   Melander, A ^a,d,e   Rastam L ^a,e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Skara Health Care Centre   (Sweden)

^c Skaraborgs Institutet   (Sweden)

^d Network for Pharmacoepidemiology Foundation   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Cardiovascular disease risk factors; Primary care; Type 2 diabetes; Uncontrolled hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROALBUMINURIA; OUTPATIENT; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SWEDEN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0344897728     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00288.x     Document Type: Article

References (32)

1. MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease, Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
2. Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267.
3. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97-104.
4. Kaplan RC, Psaty BM, Heckbert SR, Smith NL, Lemaitre RN. Blood pressure level and incidence of myocardial infarction among patients treated for hypertension. Am J Public Health 1999; 89: 1414-1417.
5. Klungel OH, Kaplan RC, Heckbert SR et al. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000; 31: 420-424.
6. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ 1990; 300: 981-983.
7. Mulrow PJ. Detection and control of hypertension in the population. The United States Experience. AJH 1998; 11: 744-746.
8. Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980; 9: 525-533.
9. Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 1987; 59: 8OA-90A.
10. Strandberg K, Beerman B, Lönnerholm G. National Board of Health and Welfare, Drug Information Committee. Treatment of Mild Hypertension. Uppsala, Sweden 1987.
11. Strandberg K, Medical Products Agency. Workshop. Treatment of hypertension in elderly people (≥70 years). Uppsala, Sweden 1993; 1: 5-32 (In Swedish).
12. Report of a WHO Study Group. World Health Organization Expert Committee. Diabetes Mellitus. Technical Report series no. 727. Geneva, Switzerland 1985.
13. Bøg-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, Råstam L. Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Int Med 1998; 243: 223-232.
14. Mogensen CE, Viberti GC, Peheim E et al. Multicenter evaluation of the Micral-test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997; 20: 1642-1646.
15. Råstam L, Sjönell G. A new device for measuring blood pressure in adults [Letter]. Lancet 1991; 337: 249-250.
16. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 1087-1092.
17. Göransson M, Hanson BS. How much can data on days with heavy drinking decrease the underestimation of true alcohol consumption? J Stud Alcohol 1994; 55: 695-700.
18. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
19. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
20. Nilsson P, Andersson DKG, Andersson P-E et al. Cardiovascular risk factors in treated hypertensives - a nationwide, cross-sectional study in Sweden. J Int Med 1993; 233: 239-245.
21. Hetlevik I, Holmen J, Krüger Ø, Holen A. Fifteen years with clinical guidelines in the treatment of hypertension - still discrepancies between intentions and practice. Scand J Prim Care 1997; 15: 134-140.
22. Cranney M, Barton S, Walley T. The management of hypertension in the elderly by general practitioners in Merseyside: the rule of halves revisited. Br J Gen Pract 1998; 48: 1146-1150.
23. Bøg-Hansen E, Lindblad U, Ranstam J, Melander A, Råstam L. Antihypertensive drug treatment in a Swedish community. The Skaraborg Hypertension Project. Pharmacoepidemiol Drug Saf 2002; 11: 45-54.
24. Seachrist D, Dunphy G, Daneshvarf H, Caplea A, Milsted A, Ely D. Testosterone increases blood pressure and cardiovascular and renal pathology in spontaneously hypertensive rats. Blood Press 2000; 9: 227-238.
25. Hauner H, Ditschuneit HH, Pal SB, Moncayo R, Pfeiffer EF. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism 1988; 37: 281-286.
26. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-873.
27. Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991; 121: 1274-1282.
28. Cruzado M, Risler N, Castro C, Ortiz A, Ruttler ME. Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels. Am J Hypertens 1998; 11: 54-58.
29. Franklin SS, Gustin W, Nathan DW et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315.
30. Psaty BM, Furberg CD, Kuller LH et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the cardiovascular health study. JAMA 1992; 268: 1287-1291.
31. Waddel TK, Dart AM, Gatzka CD, Cameron JD, Kingwell BA. Women exhibit a greater age-related increase in proximal aortic stiffness than men. J Hypertens 2001; 19: 2205-2212.
32. Sheiban I, Tonni S, Marini A, Trevi G. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Am J Cardiol 1995; 75: 23E-30E.